Skip to main content

Table 1 Patient characteristics

From: Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer

Characteristics

Age in years (median and range)

64 (42–74)

Gender (number of male and female patients)

17 / 4

ECOG-performance status (number of patients)

 0

5

 1

12

 2

4

Primary tumour (number of patients)

 Prostate cancer

4

 Colorectal cancer

3

 Renal cell cancer

2

 Hepatocellular cancer

2

 Sarcoma

2

 Glioblastoma

1

 Lung cancer

1

 Stomach cancer

1

 Pancreatic cancer

1

 Gall bladder cancer

1

 Tonsil cancer

1

 Thyroid (C-cell) cancer

1

 Thrombocythemia

1

Previous treatment (number of patients)

 Surgery

15

 Chemotherapy

14

 Radiotherapy

9

 Immunotherapy

4

Time since primary cancer diagnosis (years)

6.7 ± 8.8

Body mass index (kg/m2)

24.2 ± 5.6

Blood pressure (mmHg)

126 ± 18 / 82 ± 11

Puls rate (Beats/min)

72 ± 13

Rectal temperature (°C)

36.6 ± 0.5